StockNews.AI
SLQT
StockNews.AI
106 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SelectQuote, Inc. - SLQT

1. Pomerantz LLP investigates claims against SelectQuote for potential securities fraud. 2. The DOJ filed a lawsuit alleging kickbacks related to Medicare Advantage enrollments. 3. SelectQuote's stock dropped 19.24% to $2.56 following the lawsuit announcement. 4. Investors are advised to contact Pomerantz for joining the class action. 5. The investigation may indicate serious corporate governance issues within SelectQuote.

3m saved
Insight
Article

FAQ

Why Very Bearish?

The lawsuit and investigation have already caused a significant price drop. Historical precedents show that legal troubles can lead to prolonged declines in stock value.

How important is it?

The ongoing investigation by Pomerantz and DOJ lawsuit directly threatens SelectQuote’s financial stability. Potential liabilities and compliance issues significantly affect investor sentiment.

Why Short Term?

Immediate impact is clear due to stock price reaction; medium-term effects depend on lawsuit outcome. Legal issues generally make investors wary in the short term.

Related Companies

AETUNHCNC
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether SelectQuote and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On May 1, 2025, the U.S. Department of Justice (“DOJ”) announced the filing of a False Claims Act complaint against several health insurance companies and insurance broker organizations, including SelectQuote, “alleg[ing] that from 2016 through at least 2021, the defendant insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments into the insurers’ Medicare Advantage plans.”  On news of the DOJ’s lawsuit, SelectQuote’s stock price fell $0.61 per share, or 19.24%, to close at $2.56 per share on May 1, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes.    CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News